The immunoglobulin G fraction from plasma containing antiphospholipid antibodies causes increased placental thromboxane production

Alan M Peaceman*, Karen A. Rehnberg

*Corresponding author for this work

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

OBJECTIVE: Our objective was to evaluate whether the immunoglobulin G fraction from plasma containing high levels of antiphospholipid antibodies alters the production of prostacyclin or thromboxane when incubated with normal human placental tissue. STUDY DESIGN: The immunoglobulin G fraction was prepared from the pooled plasma of five volunteers with normal obstetric histories and no antiphospholipid antibodies. The immunoglobulin G fraction was prepared similarly from a patient with the antiphospholipid antibody syndrome. Doses of these immunoglobulin G fractions ranging from 0.3 to 3.0 mg were incubated with placental explants obtained from eight normal pregnancies, and prostacyclin and thromboxane production was assessed over 48 hours. RESULTS: Placental prostacyclin production was unaltered by incubation with either immunoglobulin G fraction at any of the doses tested. Placental thromboxane production tripled by 32 hours with the addition of 0.6, 1.5, and 3.0 mg of the antiphospholipid antibody fraction (p < 0.05) compared with baseline production but was unaltered by the addition of the normal pooled plasma fraction at any dose. The increase in thromboxane production with antiphospholipid antibody immunoglobulin G appeared to be dose related. CONCLUSION: The immunoglobulin G fraction prepared from plasma containing antiphospholipid antibodies caused increased placental thromboxane production without altering prostacyclin production.

Original languageEnglish (US)
Pages (from-to)1543-1547
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume167
Issue number6
DOIs
StatePublished - Jan 1 1992

Fingerprint

Antiphospholipid Antibodies
Thromboxanes
Immunoglobulin G
Epoprostenol
Antiphospholipid Syndrome
Obstetrics
Antibody Formation
Healthy Volunteers
Pregnancy

Keywords

  • Antiphospholipid antibodies
  • prostacyclin
  • recurrent pregnancy loss placental explants
  • thromboxane

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

@article{2e968b38beeb4d25ba8be9120f4cdeb5,
title = "The immunoglobulin G fraction from plasma containing antiphospholipid antibodies causes increased placental thromboxane production",
abstract = "OBJECTIVE: Our objective was to evaluate whether the immunoglobulin G fraction from plasma containing high levels of antiphospholipid antibodies alters the production of prostacyclin or thromboxane when incubated with normal human placental tissue. STUDY DESIGN: The immunoglobulin G fraction was prepared from the pooled plasma of five volunteers with normal obstetric histories and no antiphospholipid antibodies. The immunoglobulin G fraction was prepared similarly from a patient with the antiphospholipid antibody syndrome. Doses of these immunoglobulin G fractions ranging from 0.3 to 3.0 mg were incubated with placental explants obtained from eight normal pregnancies, and prostacyclin and thromboxane production was assessed over 48 hours. RESULTS: Placental prostacyclin production was unaltered by incubation with either immunoglobulin G fraction at any of the doses tested. Placental thromboxane production tripled by 32 hours with the addition of 0.6, 1.5, and 3.0 mg of the antiphospholipid antibody fraction (p < 0.05) compared with baseline production but was unaltered by the addition of the normal pooled plasma fraction at any dose. The increase in thromboxane production with antiphospholipid antibody immunoglobulin G appeared to be dose related. CONCLUSION: The immunoglobulin G fraction prepared from plasma containing antiphospholipid antibodies caused increased placental thromboxane production without altering prostacyclin production.",
keywords = "Antiphospholipid antibodies, prostacyclin, recurrent pregnancy loss placental explants, thromboxane",
author = "Peaceman, {Alan M} and Rehnberg, {Karen A.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/0002-9378(92)91736-T",
language = "English (US)",
volume = "167",
pages = "1543--1547",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - The immunoglobulin G fraction from plasma containing antiphospholipid antibodies causes increased placental thromboxane production

AU - Peaceman, Alan M

AU - Rehnberg, Karen A.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - OBJECTIVE: Our objective was to evaluate whether the immunoglobulin G fraction from plasma containing high levels of antiphospholipid antibodies alters the production of prostacyclin or thromboxane when incubated with normal human placental tissue. STUDY DESIGN: The immunoglobulin G fraction was prepared from the pooled plasma of five volunteers with normal obstetric histories and no antiphospholipid antibodies. The immunoglobulin G fraction was prepared similarly from a patient with the antiphospholipid antibody syndrome. Doses of these immunoglobulin G fractions ranging from 0.3 to 3.0 mg were incubated with placental explants obtained from eight normal pregnancies, and prostacyclin and thromboxane production was assessed over 48 hours. RESULTS: Placental prostacyclin production was unaltered by incubation with either immunoglobulin G fraction at any of the doses tested. Placental thromboxane production tripled by 32 hours with the addition of 0.6, 1.5, and 3.0 mg of the antiphospholipid antibody fraction (p < 0.05) compared with baseline production but was unaltered by the addition of the normal pooled plasma fraction at any dose. The increase in thromboxane production with antiphospholipid antibody immunoglobulin G appeared to be dose related. CONCLUSION: The immunoglobulin G fraction prepared from plasma containing antiphospholipid antibodies caused increased placental thromboxane production without altering prostacyclin production.

AB - OBJECTIVE: Our objective was to evaluate whether the immunoglobulin G fraction from plasma containing high levels of antiphospholipid antibodies alters the production of prostacyclin or thromboxane when incubated with normal human placental tissue. STUDY DESIGN: The immunoglobulin G fraction was prepared from the pooled plasma of five volunteers with normal obstetric histories and no antiphospholipid antibodies. The immunoglobulin G fraction was prepared similarly from a patient with the antiphospholipid antibody syndrome. Doses of these immunoglobulin G fractions ranging from 0.3 to 3.0 mg were incubated with placental explants obtained from eight normal pregnancies, and prostacyclin and thromboxane production was assessed over 48 hours. RESULTS: Placental prostacyclin production was unaltered by incubation with either immunoglobulin G fraction at any of the doses tested. Placental thromboxane production tripled by 32 hours with the addition of 0.6, 1.5, and 3.0 mg of the antiphospholipid antibody fraction (p < 0.05) compared with baseline production but was unaltered by the addition of the normal pooled plasma fraction at any dose. The increase in thromboxane production with antiphospholipid antibody immunoglobulin G appeared to be dose related. CONCLUSION: The immunoglobulin G fraction prepared from plasma containing antiphospholipid antibodies caused increased placental thromboxane production without altering prostacyclin production.

KW - Antiphospholipid antibodies

KW - prostacyclin

KW - recurrent pregnancy loss placental explants

KW - thromboxane

UR - http://www.scopus.com/inward/record.url?scp=0026740049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026740049&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(92)91736-T

DO - 10.1016/0002-9378(92)91736-T

M3 - Article

C2 - 1471662

AN - SCOPUS:0026740049

VL - 167

SP - 1543

EP - 1547

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -